GENB compared with MCRB: revenue, margins and what each company keeps, and the suppliers and customers both name

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

GENBGenerate Biomedicines, Inc.

MCRBSeres Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GENB 4

AMGNAmgencustomer

NVSNovartis Pharmacustomer

—The University of Texas MD Anderson Cancer Centerunlistedsupplier

—Roswell Park Comprehensive Cancer Centerunlistedsupplier

Shared 0

No shared counterparties.

Only MCRB 11

—Bactheraunlistedsupplier

—CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)unlistedsupplier

—Crohn's and Colitis Foundationunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Columbia Universityunlistedsupplier

7 more · MCRB chain ›

GENBGenerate Biomedicines, Inc.

13.01▲+3.49%

Mkt cap$1.6BRevenue$6MQ2 FY26

MCRBSeres Therapeutics, Inc.

2.13▲+2.00%

Regular sessionNov 6 '26

Mkt cap$21.3MRevenue$593,000Q3 FY26

Compare

Regular sessionNov 6 '26

GENBGenerate Biomedicines, Inc.

MCRBSeres Therapeutics, Inc.

13.01▲+3.49%

Price

2.13▲+2.00%

$1.6B

Mkt cap

$21.3M

Q2 FY26$6M

Revenue

$593,000Q3 FY26

GENB13.01▲+3.49%vsMCRB2.13▲+2.00%Regular sessionNov 6 '26